Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.52 | 32.77 |
PEG Ratio (TTM) | 0.01 | 7.92 |
P/S Ratio (TTM) | 0.52 | 1.41 |
P/B Ratio (TTM) | 3.97 | 4.51 |
P/FCF Ratio (TTM) | -0.57 | 17.69 |
Price to 5YR AVG Earnings Ratio | N/A | -55.14 |
Price to 5YR AVG FCF Ratio | N/A | 17.93 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -65.40% | 2.29% |
ROE (TTM) | -226.92% | 21.41% |
Net Profit Margin (TTM) | -82.52% | -5.24% |
ROIC 5YR AVG | N/A | 19.33% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | N/A | 319.64% | N/A |
Revenue | N/A | -2.96% | N/A |
Net Income | N/A | 260.37% | N/A |
Cash Flow | N/A | -139.17% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.76 | 1.26 |
Quick Ratio (TTM) | 1.85 | 1.21 |
D/E Ratio (TTM) | 0.85 | 0.99 |
Interest Coverage (TTM) | -19.10 | 0.29 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 2.04 |
LTL to 5YR AVG FCF | N/A | 5.03 |
Shares Outstanding Growth 5YR AVG | N/A | 15.61% |